Evaluation of Inflammatory Markers in Patients with COVID-19 Combined with Type 2 Diabetes Mellitus
Jingjing Li,Yu Zhang,Rui Wu,Guodong Ma,Li Sheng,Yun Feng,Yang Han,Lina Zhang,Janfeng Guo,Rongbo Li
DOI: https://doi.org/10.2147/rmhp.s490281
2024-10-27
Risk Management and Healthcare Policy
Abstract:Jingjing Li, 1 Yu Zhang, 2 Rui Wu, 1 Guodong Ma, 1 Li Sheng, 1 Yun Feng, 1 Yang Han, 1 Lina Zhang, 1 Janfeng Guo, 1 Rongbo Li 1 1 Department of Infectious Diseases, Hohhot First Hospital, Hohhot, Inner Mongolia Autonomous Region, 010000, People's Republic of China; 2 Department of Dermatology and Venereology, Hohhot, Inner Mongolia Autonomous Region People's Hospital, 010000, People's Republic of China Correspondence: Jingjing Li, Department of Infectious Diseases, Hohhot First Hospital, No. 148, South Second Ring Road, Zhaojun Road, Yuquan District, Hohhot, Inner Mongolia Autonomous Region, 010000, Tel +86-18047422188, Email Purpose: To explore the value of different inflammatory markers in predicting the severity of coronavirus disease 2019 (COVID-19) in patients with type 2 diabetes mellitus (T2DM). Patients and Methods: A total of 116 patients with COVID-19 in patients with T2DM were collected from December 2022 to March 2023 and were divided into a mild case group (77 cases) and a severe case group (39 cases). The ratio of neutrophil to lymphocyte (NLR), platelet-to-lymphocyte ratio (PLR), neutrophil to lymphocyte × platelet ratio (NLPR), lymphocyte ratio to monocyte (LMR), systemic inflammatory response index (SIRI), systemic inflammatory index (SII), systemic inflammatory composite index (AISI), procalcitonin (PCT), C-reactive protein (CRP) and lactate dehydrogenase (LDH) were compared between the two groups. The screening effect of each variable on the progression of the disease was analyzed using receiver operating characteristic (ROC) curves. Results: NLR, PLR, NLPR, MLR, SIRI, SII, AISI, LDH, CRP and PCT in severe case group were higher than those in mild case group ( P < 0.05), and LMR was lower than those in mild case group ( P < 0.05). ROC curve analysis further demonstrated the diagnostic performance of these biomarkers, with PCT having the largest area under the ROC curve (AUC ROC ) of 0.83. Conclusion: NLR, PLR, NLPR, SIRI, SII, LDH, CRP and PCT demonstrate greater reliability in diagnostic value and clinical utility for predicting the severity of COVID-19 in patients with T2DM. Keywords: COVID-19, T2DM, inflammatory index, LDH, CRP, PCT The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. It is a highly infectious and pathogenic disease. It is characterized by severe inflammatory response and a wide range of clinical manifestations, which can progress from mild flu-like symptoms and fever to adult respiratory distress syndrome (ARDS), coagulation dysfunction, and even death. 1 According to the latest data from the World Health Organization, more than 7 million people have died from COVID-19 globally since the outbreak began in late 2019, with the most deaths reported in the United States (1.2 million), Brazil (702,000), India (534,000) and Russia (403,000). 2 Studies have shown that angiotensin-converting enzyme 2 was the target of SARS-CoV-2 infection, 3 and angiotensin-converting enzyme 2 receptors were commonly expressed in alveolar type I and type II epithelial cells and were also found in several organs such as the pancreas. 4 A meta-analysis has shown that diabetes mellitus (DM) was the most important cause of death among hospitalized patients with COVID-19, with a 1.85-fold increased risk of death. 5 Therefore, identifying some early biomarkers of the severity of COVID-19 in patients with type 2 diabetes (T2DM) may help to aggressively treat the disease at an early stage and reduce mortality. Routine blood tests can be used to assess inflammatory status and aid in early diagnosis of the disease. Blood tests, in particular, are readily available and inexpensive, and can provide information about a variety of cell parameters, such as white blood cell counts, lymphocytes, neutrophils, etc. In addition, the ratio combination of these parameters is also used as an indicator of inflammation. Examples include neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), neutrophil to lymphocyte × platelet ratio (NLPR), systemic inflammatory Response Index (SIRI), systemic inflammatory index (SII), and systemic inflammatory composite Index (AISI) and other indicators can be used as biomarkers to assist disease and risk stratification. 6–8 However, few studies have examined the value of these measures in assessing disease severity in patients with COVID-19 in patients with T2DM. Therefore, we attempted to compare the ability of NLR, PLR, MLR, NLPR, SIRI, SII, AISI, etc. to predict d -Abstract Truncated-
health care sciences & services,health policy & services